Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

Autor: Stupp, R, Mason, Wp, VAN DEN BENT MJ, Weller, M, Fisher, B, Taphoorn, Mj, Belanger, K, Brandes, Aa, Marosi, C, Bogdahn, U, Curschmann, J, Janzer, Rc, Ludwin, Sk, Gorlia, T, Allgeier, A, Lacombe, D, Cairncross, Jg, Eisenhauer, E, Mirimanoff, Ro, Soffietti, Riccardo, NATIONAL CANCER INSTITUTE OF CANADA CLINICAL TRIALS GROUP

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______970::fe7645014404d82afee6963266bb78f9
http://hdl.handle.net/2318/35760

Age and comorbidity as independent prognostic factors in the treatment of non small-cell lung cancer: a review of National Cancer Institute of Canada Clinical Trials Group trials.

Autor: Asmis TR, Ding K, Seymour L, Shepherd FA, Leighl NB, Winton TL, Whitehead M, Spaans JN, Graham BC, Goss GD, National Cancer Institute of Canada Clinical Trials Group

Publikováno v: Journal of Clinical Oncology; 1/1/2008, Vol. 26 Issue 1, p54-59, 6p

Phase II study of vandetanib or placebo in small-cell lung cancer patients after complete or partial response to induction chemotherapy with or without radiation therapy: National Cancer Institute of Canada Clinical Trials Group Study BR.20.

Autor: Arnold AM, Seymour L, Smylie M, Ding K, Ung Y, Findlay B, Lee CW, Djurfeldt M, Whitehead M, Ellis P, Goss G, Chan A, Meharchand J, Alam Y, Gregg R, Butts C, Langmuir P, Shepherd F, National Cancer Institute of Canada Clinical Trials Group Study BR.20, Arnold, Andrew M

Publikováno v: Journal of Clinical Oncology; 9/20/2007, Vol. 25 Issue 27, p4278-4284, 7p

Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group.

Autor: Moore MJ, Goldstein D, Hamm J, Figer A, Hecht JR, Gallinger S, Au HJ, Murawa P, Walde D, Wolff RA, Campos D, Lim R, Ding K, Clark G, Voskoglou-Nomikos T, Ptasynski M, Parulekar W, National Cancer Institute of Canada Clinical Trials Group

Publikováno v: Journal of Clinical Oncology; 5/20/2007, Vol. 25 Issue 15, p1960-1966, 7p

Comparison of toxicity associated with early morning versus late afternoon radiotherapy in patients with head-and-neck cancer: a prospective randomized trial of the National Cancer Institute of Canada Clinical Trials Group (HN3)

Autor: Bjarnason GA (AUTHOR), Mackenzie RG (AUTHOR), Nabid A (AUTHOR), Hodson ID (AUTHOR), El-Sayed S (AUTHOR), Grimard L (AUTHOR), Brundage M (AUTHOR), Wright J (AUTHOR), Hay J (AUTHOR), Ganguly P (AUTHOR), Leong C (AUTHOR), Wilson J (AUTHOR), Jordan RC (AUTHOR), Walker M (AUTHOR), Tu D (AUTHOR), Parulekar W (AUTHOR), National Cancer Institute of Canada Clinical Trials Group (HN3) (CORPORATE AUTHOR)

Publikováno v: International Journal of Radiation Oncology, Biology, Physics. Jan2009, Vol. 73 Issue 1, p166-172. 7p.